LeSPAR comment on the BMJ article on antibiotic course duration

The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) has noted with interest the publication of a BMJ article by Llewelyn et al. on antibiotic course duration.



The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) has noted with interest the publication of a BMJ article by Llewelyn et al. on antibiotic course duration.

Professor David Webb, President of the British Pharmacological Society, commented on behalf of LeSPAR: “We welcome debate that will inform and promote effective antibiotic prescribing. LeSPAR’s concern is that there must be sufficient evidence to support any change in policy. We support the position of the Chief Medical Officer that the message to the public remains the same: Patients should continue to follow the advice of their own doctor, nurse or pharmacist.” He continued, “LeSPAR supports the need for further research to inform the updating and monitoring of policies and any consequent changes to practice that might be required.”

For further information or comment from LeSPAR, please contact [email protected].